Novo Nordisk wins FDA label expansion for Wegovy against liver disease MASH Seeking Alpha Novo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH Reuters Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis PR Newswire Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH Yahoo Finance Novo Nordisk’s obesity …
Read More »Tag Archives: MASH
Novo Nordisk’s obesity drug Wegovy cleared to treat live disease MASH
Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators on Friday to treat an increasingly common liver disease, adding to the list of conditions for which the blockbuster therapy is now approved. The Food and Drug Administration granted accelerated approval to Wegovy for patients with metabolic dysfunction-associated steatohepatitis, or MASH, with moderate to advanced liver scarring. The decision was …
Read More »Novo Nordisk's Wegovy gets accelerated US approval for liver disease MASH – Reuters
Novo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH Reuters Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis PR Newswire Novo Nordisk’s obesity drug Wegovy cleared to treat MASH statnews.com Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH Yahoo Finance Novo Nordisk’s Wegovy Gets US Approval for …
Read More »